Article Key Takeaway: What does the 2026 IPO wave mean for index funds and retirement plans?
- Index funds still involve active decisions—just not by you.
Choosing an index fund delegates security selection to index providers, whose rules determine what your plan owns. - Not all indexes treat IPOs the same.
The same company may be added to one index within ~15 days but delayed for years—or never included—in another, depending on provider rules. - “It’s in your 401(k)” headlines are often misleading.
Newly public companies typically enter indexes with very small weights due to limited publicly traded shares (float), even if their valuations are massive. - 2026’s IPO wave is unusually impactful.
With an estimated ~$160 billion in IPO activity and large AI-driven companies dominating, new listings are big enough to influence major benchmarks. - Index inclusion is now a multi-stage process.
As lockups expire and more shares become tradable, index weights can increase over time—meaning exposure grows gradually, not all at once. - Different rulebooks create different outcomes.
S&P (profitability + seasoning), Nasdaq (fast entry), CRSP, FTSE, and MSCI all apply distinct methodologies—leading to materially different exposures across “index” funds. - This affects diversification and concentration.
Many IPOs are highly correlated megacap growth names, potentially increasing concentration in already top-heavy indexes. - Most due diligence misses the real risk.
Traditional focus on fees and tracking error overlooks the index methodology itself, which is what actually shapes portfolio exposure. - Fiduciaries don’t need to react—but they do need to understand.
The prudent move is not to intervene, but to document awareness, review methodology, and communicate clearly with participants. - The core insight:
Passive investing didn’t eliminate decision-making—it moved it to index committees whose rules are now changing.
Full Article
A record year for new listings is quietly reshaping the index funds at the core of most retirement plans. The mechanics matter less than a question every fiduciary should be able to answer: who is actually choosing what your plan owns?
Here's a fact worth sitting with. The same newly public company can join one major U.S. stock index within roughly 15 trading days of its first trade and remain ineligible for another until 2027, if it ever qualifies at all—same company, same shares, same week on the calendar. The only thing that differs is whose rulebook you happen to be reading.
That gap is not a technicality. For the retirement plans that have spent two decades migrating toward low-cost index funds, and for the participants whose balances sit in target-date and index options, it raises a question most committees have never had reason to ask: when you "buy the index," who decides what goes into it?
In 2026, that question has teeth. Goldman Sachs has estimated roughly $160 billion in U.S. IPO proceeds this year, among the largest annual totals on record. The pipeline is dominated by very large, AI-adjacent names, SpaceX first out of the gate, with the likes of OpenAI, Anthropic, and ByteDance frequently mentioned behind it. These are not the small-cap debuts of a typical year. They are big enough to move the benchmarks that sit at the center of your plan.
The headline that isn't quite true
When SpaceX listed, the predictable headline followed within hours: SpaceX is now in your 401(k). A committee member will forward that article to you. It deserves a calm, precise answer.
The honest version is that the exposure is potentially real but small, far smaller than the headline implies. The reason is float. Major indexes are float-weighted, not by a company's total value but by its *investable* value: the shares actually available to trade. At its IPO, only a thin slice of SpaceX, roughly 5%, was floated to the public. So despite a headline valuation that ranks it among the largest companies in the country, its weight in a broad index enters as a rounding error rather than a heavyweight.
The Good News: the sky is not falling, and there is nothing to react to on day one. But "nothing to react to" is not the same as "nothing to understand." The interesting part isn't the size of the position. It's how it got there.
The decision you delegated
Choosing an index fund may feel like a decision not to make decisions. You are declining to bet on individual stocks, to pay someone to pick them, and to accept the market's collective judgment instead. That instinct is sound, and it has saved plan participants an enormous amount in fees and underperformance over the years.
But indexing does not eliminate security selection. It relocates it. Every index is built on a rulebook with eligibility criteria, seasoning periods, float thresholds, profitability tests, style definitions, and a committee that maintains those rules and decides which companies clear them. When your plan adopts an index fund, you are hiring that rulebook and that committee. You have delegated security selection; you have not escaped it.
For most of the last two decades, that delegation was invisible, because the rulebooks were stable and the additions were uncontroversial. The 2026 IPO wave is making the delegation visible again, because the rulebooks have changed, and the rule-makers don't agree with each other.
The rulebooks changed
Here is where the opening fact comes from. Faced with a class of enormous, often unprofitable, thinly floated new companies, the major index providers made different choices about whether and how fast to let them in.
S&P held its line. Its flagship index still requires a company to be GAAP-profitable and to season for a period before it can be considered, and it has declined to waive those standards simply because a company is large. On that path, a name like SpaceX waits, likely into 2027 at the earliest, and only if it turns profitable.
Others built express lanes. Nasdaq adopted a "fast entry" rule that can admit a large, liquid IPO to its marquee index in roughly 15 trading days. CRSP, a provider of broad-market indexes that underlies many total-market funds can pick up a qualifying new listing within days. FTSE Russell folds eligible IPOs in on a quarterly cadence. MSCI created its own accelerated treatment for large debuts. Each provider has, in effect, written a different answer to the same question.
The practical consequence lands squarely in your fund lineup. Two participants, both in "index funds," can end up with materially different exposure to the same company at materially different times; not because either made a choice, but because their funds track different benchmarks maintained by different committees applying different rules. The most consequential change to what your plan owns this year may have been made by people you will never meet, under rules you have never read, and they were changed without notice to you.
Why a fiduciary should care
Delegation is entirely defensible. Prudent fiduciaries delegate all the time, and indexing remains one of the better delegations available. But delegation does not extinguish the duty to understand what you handed off and to whom, and a few features of this particular wave deserve a committee's attention.
It isn't a one-time event. Because these companies float so few shares at first, index inclusion has become a multi-stage process. As post-IPO lockups expire and more shares become tradable, a company's index weight mechanically rises, pulling more passive dollars in behind it.
It concentrates more than it diversifies. The names driving this wave are heavily correlated, and they are flowing into index segments that are already top-heavy by historical standards. A growth index whose three largest holdings already account for roughly a third of the fund does not become more diversified by adding another correlated megacap.
And most due-diligence files won't capture any of it. Typical index-fund reviews focuses on tracking error and expense ratios. Those are the right questions for how well a fund follows its benchmark. They say nothing about what the benchmark's rules are or whether they recently changed, which, this year, is the thing that actually moved your portfolio.
What a prudent committee does
The goal here is informed oversight, not reactive tinkering. Concretely:
- Resist the urge to screen. Trying to carve these names out of an index option defeats the purpose of indexing, invites tracking error, and substitutes the committee's market judgment for the discipline the index was designed to provide. Restraint is the prudent default.
- Add methodology to your due diligence. Alongside fees and tracking error, ask each index provider the questions that now matter: How do you treat IPO seasoning, float, and profitability? Have those rules changed recently? Knowing the answer is the difference between delegating knowingly and delegating blindly.
- Document that you understood it. The fiduciary standard rewards process, not outcomes. Minuting that the committee discussed the IPO wave and its index implications, even where you take no action, is itself a demonstration of prudence.
- Pre-load the participant's answer. Be ready for the "Is SpaceX in my account?" question before it arrives. Lead with the float reality: yes, in a small and growing way, by virtue of owning the market, not because anyone placed a bet.
The reframe
Passive investing did not remove the decision about what your plan owns. It relocated the decision to a handful of index committees whose rules are consequential, currently in flux, and quietly different from one another. That is not an argument against indexing.
It is an argument for knowing what you've delegated. The prudent fiduciary's job is not to second-guess the index committee. It is to recognize that one is making decisions on the plan's behalf, to understand the rules it plays by, and to document that understanding. In a year when the rulebooks are being rewritten in real time, that awareness, calm, and being informed and on the record are the whole job.
Multnomah Group is a registered investment adviser registered with the Securities and Exchange Commission. Any information contained herein or on Multnomah Group’s website is provided for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and, unless otherwise stated, are not guaranteed. Multnomah Group does not provide legal or tax advice.